Market Size of Global Industrial Microbiology Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 6.90 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Industrial Microbiology Market Analysis
The industrial microbiology market is expected to register a CAGR of 6.9% during the forecast period (2022 - 2027).
The emergence of the COVID-19 pandemic had a significant impact on the global economy, which not only impacted the healthcare sector but other sectors too. The restrictions imposed by respective governments across the world to curb the spread of infections led to disruption in services like manufacturing, sample testing, research, and development activities other than COVID-19, pharmaceutical and biotechnology supply chain, which had their impact on the industrial microbiology market. For instance, according to the research study published in October 2021, titled 'Impact of COVID19 on agricultural production and distribution in South Asia', in India, Bangladesh, and Pakistan, the agriculture sector was severely impacted as the COVID-19 emerged in these regions during harvest time, and thus, production, distribution and other activities were impacted for agriculture products in these countries.
However, according to an article published by the Elsevier Public Health Emergency Collection, in December 2021, titled 'Dietary supplements and nutraceuticals market growth during the coronavirus pandemic - Implications for consumers and regulatory oversight', it has been observed that before the pandemic, the dietary supplement sales in the United States increased by 5% to USD 345 million in 2019 and there was a 44% (USD 435 million) rise in sales in the six weeks before April 5th, 2020, during the first wave of the pandemic as compared to the same period in 2019. In addition, as per the same source, multivitamin sales increased by 51.2% in March 2020 in the United States, and nearly 120 million units of vitamins and supplements were sold during that period. Furthermore, vitamin sales increased by 63% in the United Kingdom, and in France, sales grew by approximately 40-60% in March 2020. Thus, the increased sales of multivitamins, probiotics, and other products in the countries to maintain and improve the immune system is expected to significantly impact the studied market. Likewise, COVID-19 also led to new norms for microbial testing in various industries worldwide. With decreasing COVID-19 cases, the studied market is expected to regain its full potential during the forecast period of the study.
Nutraceutical and fermented food products are gaining traction worldwide and playing an important role in food security; thus, with an increase in their global demand, the need for advanced testing is also increasing to maintain the quality and integrity of the products. Hence, the demand for products used in industrial microbiology is increasing worldwide, which is expected to be a major growth factor for the growth of the industrial microbiology market during the forecast period of the study. For instance, according to the Ministry of Food Processing Industries of the Government of India, the nutraceuticals market was USD 4 billion in India in 2020. Further, as to the same source, the nutraceutical market is expected to grow by 7% from 2019 to 2024 in the country. The Indian population has started to believe in immunity-boosting supplements, which has significantly changed buying patterns of consumer behavior and market behavior. Additionally, the United States saw many developments concerning clinical nutrition. For instance, in November 2021, Abbott launched Similac 360 Total Care, the first and only infant formula in the United States with a blend of five different Human Milk Oligosaccharides (HMOs), previously only found together in breast milk. The product provides nutrition to support a baby's complete health and development, including the immune system, digestive system, and brain. With the increasing demand for vitamin capsules, chewable tablets, and other nutraceutical products for treating various conditions in populations, especially pediatric and geriatric populations, all over the world is expected to increase the demand for microbiology testing to assuring the quality of the products and thus, the industrial microbiology market is expected to grow over the forecast period.
Other major factors that are expected to positively impact the industrial microbiology market include increasing research and development expenditure in industrial microbiology and the launch of new and advanced products that can improve or enhance industrial microbiology procedures. For instance, in June 2022, STEMart launched comprehensive microbiological and sterility testing services for sterile, non-pyrogenic products. Additionally, in December 2021, in India, ÄKTA Nutrition partnered with Sundyota Numandis Group to launch a nutraceutical product line utilizing quality ingredients. The product offerings include Bye-Bye Stress (which promotes relaxation and sleep), Good Immunity (which promotes the body's natural capacity to fight against infections), and Beet Strong (which promotes overall well-being with added benefits of beetroot). Similarly, in July 2020, Neogen Corporation launched an advanced test system, Soleris Next Generation (NG), which automatically detects microorganisms in a fraction of the time of traditional testing methods. The system rapidly detects a wide variety of microorganisms to provide safe and high-quality food and cosmetic products. Thus, increasing product launches and rising company activities are expected to increase the demand for microbiology testing products which is anticipated to fuel the market growth over the forecast period.
However, factors such as conflicts regarding the usage of genetically modified organisms in food sources and increasing product recalls are expected to restrain the growth of the industrial microbiology market during the forecast period.
Industrial Microbiology Industry Segmentation
As per the scope of the report, Industrial Microbiology is a branch of applied microbiology in which microorganisms are used in industrial processes, for example, in the production of high-value products such as drugs, chemicals, food products, and cosmetics. The industrial microbiology market is segmented by product type (equipment and systems, consumables, and reagents), application area (food and beverage industry, pharmaceutical biotechnology industry, agriculture industry, environmental industry, cosmetic or personal care industry, and other application areas), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.
By Product Type | |
Equipment and Systems | |
Consumables | |
Reagents |
By Application Area | |
Food and Beverage Industry | |
Pharmaceutical and Biotechnology Industry | |
Agricultural Industry | |
Environmental Industry | |
Cosmetic or Personal Care Industry | |
Other Application Areas |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Industrial Microbiology Market Size Summary
The industrial microbiology market is poised for significant growth, driven by increasing demand for advanced testing and quality assurance in various sectors, including pharmaceuticals, biotechnology, and food industries. The market's expansion is supported by the rising global interest in nutraceuticals and fermented food products, which necessitate stringent microbiological testing to ensure product integrity. The COVID-19 pandemic has also played a role in shaping the market dynamics, as it led to new norms for microbial testing and heightened awareness of health and immunity-boosting products. As the world moves past the pandemic, the market is expected to regain its momentum, with the pharmaceutical and biotechnology sectors, in particular, witnessing substantial growth due to increased research and development activities and the demand for life-saving drugs and therapies.
North America is anticipated to dominate the industrial microbiology market, fueled by significant investments in research and development by pharmaceutical, biotechnology, and food companies in the region. The United States, with its large-scale pharmaceutical and food companies, is expected to hold a major share, supported by the launch of new products and the expansion of testing facilities. The competitive landscape of the market is characterized by the presence of key players such as bioMerieux SA, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, and Qiagen NV, who are actively involved in product innovation and strategic partnerships. These factors, combined with the increasing adoption of business strategies like partnerships and agreements, are expected to drive the market's growth over the forecast period.
Global Industrial Microbiology Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Preference for Nutraceuticals and Other Fermented Products
-
1.2.2 Increasing Research and Development Expenditure and Increasing Innovation
-
1.2.3 Rising Concern for Food Safety
-
-
1.3 Market Restraints
-
1.3.1 Conflicts Regarding Usage of Genetically Modified Organisms in Food Sources
-
1.3.2 Increasing Product Recalls
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value- USD Million)
-
2.1 By Product Type
-
2.1.1 Equipment and Systems
-
2.1.2 Consumables
-
2.1.3 Reagents
-
-
2.2 By Application Area
-
2.2.1 Food and Beverage Industry
-
2.2.2 Pharmaceutical and Biotechnology Industry
-
2.2.3 Agricultural Industry
-
2.2.4 Environmental Industry
-
2.2.5 Cosmetic or Personal Care Industry
-
2.2.6 Other Application Areas
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Industrial Microbiology Market Size FAQs
What is the current Global Industrial Microbiology Market size?
The Global Industrial Microbiology Market is projected to register a CAGR of 6.90% during the forecast period (2024-2029)
Who are the key players in Global Industrial Microbiology Market?
bioMerieux SA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company and Qiagen NV are the major companies operating in the Global Industrial Microbiology Market.